Stay updated on Paltusotine in Acromegaly: Safety and Efficacy Clinical Trial
Sign up to get notified when there's something new on the Paltusotine in Acromegaly: Safety and Efficacy Clinical Trial page.

Latest updates to the Paltusotine in Acromegaly: Safety and Efficacy Clinical Trial page
- Check2 days agoChange DetectedResults have been posted for PATHFNDR-2, including IGF-1 biochemical response at Week 24, changes from baseline in IGF-1, GH <1 ng/mL at Week 22, and changes in the Acromegaly Symptoms Diary. Related documents (Study Protocol and Statistical Analysis Plan) and results posting dates are also listed.SummaryDifference2%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedLocations (participating sites) were expanded with new sites in the United States, Argentina, Brazil, China, and India, among others. Some previously listed locations were removed, and a revision note shows the page updated to v3.3.3.SummaryDifference2%

- Check52 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2 on the Study Details page. This appears to be a general site version update with no visible changes to trial content.SummaryDifference0.0%

- Check59 days agoChange DetectedThe government funding operating-status notice/banner was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check73 days agoChange DetectedThe changes shown appear to be minor UI/formatting adjustments with no alteration to core study information (title, criteria, interventions, outcomes, or locations). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check81 days agoChange DetectedThe study record now shows 'Results Submitted' instead of 'No Results Posted'.SummaryDifference0.0%

Stay in the know with updates to Paltusotine in Acromegaly: Safety and Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Paltusotine in Acromegaly: Safety and Efficacy Clinical Trial page.